Exelixis
EXEL
#1851
Rank
C$15.00 B
Marketcap
C$55.98
Share price
-0.10%
Change (1 day)
-0.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company